Literature DB >> 19933687

Primary urothelial carcinoma of the upper urinary tract in dialysis patients with 5-year follow-up.

Chih-Hsiung Kang1, Chien-Hsu Chen, Po-Hui Chiang.   

Abstract

OBJECTIVE: In this study, we assessed the clinical and pathological characteristics of urothelial cancers of the upper urinary tract (UUT) in patient under dialysis and evaluated the efficacy and complications of surgical management of the disease.
METHODS: A total of 70 dialysis patients with primary urothelial carcinoma (UC) of the UUT were identified with 5-year follow-up after surgery (61-122 months). Potential factors were analysed to determine the risk factors of subsequent tumours and unfavourable prognostic factors of overall survival. Incidence of urothelial tumours and overall survival of 7503 dialysis patients were also evaluated.
RESULTS: The incidence of primary UC of the UUT in dialysis patients in Taiwan was 0.93%. The 2-year and 5-year overall survival rates of dialysis patients with primary UC of the UUT were 74.3% and 42.9%, respectively. Subsequent bladder tumours and contralateral UUT tumours developed in 52.6% and 37.9% patients, respectively. No significant risk factor could be identified to predict subsequent tumours in dialysis patients. Pathological stage (P = 0.021) and grade (P < 0.001) were the unfavourable prognostic factors in the log-rank test. No significant difference was observed in perioperative mortality and overall survival between patients receiving one-stage nephroureterectomy and those receiving two-stage bilateral nephroureterectomy; however, the cystectomy procedure increased perioperative mortality according to the chi(2) test (P = 0.042).
CONCLUSIONS: Closely monitoring the residual urinary tracts after nephroureterectomy in dialysis patients with primary UC of the UUT should be performed. There is no statistical difference for overall survival between one-stage and two-stage bilateral nephroureterectomy.

Entities:  

Mesh:

Year:  2009        PMID: 19933687     DOI: 10.1093/jjco/hyp143

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  10 in total

1.  Treatment strategy for bladder cancer in patients on hemodialysis: a clinical review of 28 cases.

Authors:  Yasuyuki Sato; Tsunenori Kondo; Toshio Takagi; Iizuka Junpei; Kazunari Tanabe
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

2.  Two-year death and loss to follow-up outcomes by source of referral to HIV care for HIV-infected patients initiating antiretroviral therapy in rural Mozambique.

Authors:  Meridith Blevins; Eurico José; Fernandes R Bilhete; Lara M E Vaz; Bryan E Shepherd; Carolyn M Audet; Sten H Vermund; Troy D Moon
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12-17       Impact factor: 2.205

3.  The incidence and prevalence of upper tract urothelial carcinoma: a systematic review.

Authors:  Ahmed Soualhi; Elke Rammant; Gincy George; Beth Russell; Deborah Enting; Rajesh Nair; Mieke Van Hemelrijck; Cecilia Bosco
Journal:  BMC Urol       Date:  2021-08-17       Impact factor: 2.264

4.  Upper urinary tract urothelial carcinoma behaviors in patients with end-stage renal disease after kidney transplantation in Taiwan.

Authors:  Chia-Shen Chien; Hao Lun Luo; Chou Shu Ling; Po-Hui Chiang; Yen-Ta Chen; Yuan Tso Cheng
Journal:  Int Urol Nephrol       Date:  2016-05-18       Impact factor: 2.370

5.  Shorter hemodialysis duration is a risk factor for the recurrence of urothelial carcinoma of the bladder in patients on maintenance hemodialysis.

Authors:  S-L Liu; L Qi; W-Q Han; B-S Zhu; X Zhou; S-S Jiang; M-F Chen; Y Li; W He; L-F Liu; X-H Hu; Y Xie; F-H Zeng; X-B Zu
Journal:  Clin Transl Oncol       Date:  2015-07-29       Impact factor: 3.405

6.  Chronic kidney disease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer.

Authors:  Chia-En Li; Chia-Shen Chien; Yao-Chi Chuang; Ye-In Chang; Hsiu-Pei Tang; Chih-Hsiung Kang
Journal:  Int Urol Nephrol       Date:  2016-03-19       Impact factor: 2.370

Review 7.  Upper tract urothelial carcinomas in patients with chronic kidney disease: relationship with diagnostic challenge.

Authors:  Li-Jen Wang; Shen-Yang Lee; Bin Tean Teh; Cheng-Keng Chuang; Joëlle Nortier
Journal:  Biomed Res Int       Date:  2014-08-07       Impact factor: 3.411

Review 8.  Interplay between chronic kidney disease (CKD) and upper tract urothelial carcinomas (UUC): foe or friend?

Authors:  Yehong Han; Dawei Shou; Liang Wen; Jianguang Shi; Jian Ding; Ping Gong; Weihua Gong
Journal:  Oncotarget       Date:  2016-08-16

9.  Incidence of Bladder Cancer in Type 2 Diabetes Mellitus Patients: A Population-Based Cohort Study.

Authors:  Yueh Pan; Chia-Yi Lee; Liang-Ming Lee; Yu-Ching Wen; Jing-Yang Huang; Shun-Fa Yang; Chi-Hao Hsiao
Journal:  Medicina (Kaunas)       Date:  2020-08-31       Impact factor: 2.430

10.  Nephroureterectomy increase 5 year survival in patients on dialysis with upper urinary tract urothelial carcinoma.

Authors:  Cih-En Huang; Yao-Hsu Yang; Wen-Cheng Chen; Kuo-Tsai Huang; Pau-Chung Chen; Ying-Huang Tsai; Wei-Yu Lin
Journal:  Oncotarget       Date:  2017-08-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.